આજે જાહેર થશે મહત્વના કંપની પરીણામોઃ Dr Reddy’s Lab, L&T, SRF, Voltas, BAJAJFINSV, BAJAJHLDNG, BHARATGEAR, STAR, આજે EPACK Durableનું લિસ્ટિંગ

Listing of EPACK Durable

Q3FY24 EARNING CALENDAR 30.01.2024: APARINDS, ATGL, BAJAJFINSV, BAJAJHLDNG, BHARATGEAR, BLUESTARCO, DRREDDY, GILLETTE, IMFA, JBMA, JCHAC, JPASSOCIAT, JUBLINGREA, KAYNES, KEC, KPITTECH, LT, M&MFIN, NDTV, POLICYBZR, PPLPHARMA, SAINTGOBAIN, SHYAMMETL, SIS, SRF, STAR, STARHEALTH, SUBROS, SYMPHONY, TEAMLEASE, TEXINFRA, TRIVENI, VAIBHAVGBL, VIPIND, VOLTAS, ZFCVINDIA

Dr Reddy’s Lab

Revenue expected at Rs 6904 crore versus Rs 6770 crore

EBITDA expected to be seen at Rs 1972 crore versus Rs 1966 crore

EBITDA margin expected to be seen at 28.6% versus 29.0%

Net profit expected to be seen at Rs 1294 crore versus of Rs 1247 crore

L&T

Revenue expected at Rs 53,516 crore versus Rs 46,389 crore

EBITDA expected to be seen at Rs 5894 crore versus Rs 5073 crore

EBITDA margin expected to be seen at 11.0% versus 10.9%

Net profit expected to be seen at Rs 3309 crore versus of Rs 2553 crore

SRF

Revenue expected at Rs 3146 crore versus Rs 3469 crore

EBITDA expected to be seen at Rs 641 crore versus Rs 833 crore

EBITDA margin expected to be seen at 20.3% versus 24.0%

Net profit expected to be seen at Rs 321 crore versus of Rs 510 crore

Voltas

Revenue expected at Rs 2417 crore versus Rs 2005 crore

EBITDA expected to be seen at Rs 105 crore versus Rs 76.3 crore

EBITDA margin expected to be seen at 4.34% versus 3.80%

Net profit expected to be seen at Rs 78 crore versus of Rs 27 crore

Q3FY24 EARNING CALENDAR 31.01.2024: AJANTPHARM, AMBUJACEM, ARE&M, AWL, BALAMINES, BANKBARODA, CARBORUNIV, DABUR, DATAPATTNS, DBREALTY, DCMSHRIRAM, DIXON, GESHIP, GMRINFRA, GODREJCP, IDFC, IRB, JINDALSTEL, JUBLFOOD, JYOTHYLAB, KAJARIACER, KALYANKJIL, MANKIND, MARUTI, MAXHEALTH, MOREPENLAB, MSUMI, NIITMTS, NILKAMAL, PGHH, POLYMED, PSB, PVRINOX, RELAXO, SHREECEM, SUNPHARMA, SUZLON, SWANENERGY, THOMASCOOK, WELSPUNLIV, WESTLIFE

(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)

(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)